APA (7th ed.) Citation

Niza, E., Castro-Osma, J. A., Posadas, I., Alonso-Moreno, C., Bravo, I., Garzón, A., . . . Otero, A. (2019). Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma. International Journal of Pharmaceutics, 558, 110. https://doi.org/10.1016/j.ijpharm.2018.12.079

Chicago Style (17th ed.) Citation

Niza, Enrique, et al. "Assessment of Doxorubicin Delivery Devices Based on Tailored Bare Polycaprolactone Against Glioblastoma." International Journal of Pharmaceutics 558 (2019): 110. https://doi.org/10.1016/j.ijpharm.2018.12.079.

MLA (9th ed.) Citation

Niza, Enrique, et al. "Assessment of Doxorubicin Delivery Devices Based on Tailored Bare Polycaprolactone Against Glioblastoma." International Journal of Pharmaceutics, vol. 558, 2019, p. 110, https://doi.org/10.1016/j.ijpharm.2018.12.079.